Highlights from the 30th Annual International Prostate Cancer Update
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference...
Read MoreSelect Page
Posted by Rusty Speidel | Mar 2020
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference...
Read MorePosted by Rusty Speidel | Aug 2019
Discussion of FDA Industry Guidelines for Developing Gonadotropin-Releasing Hormone Analogues for...
Read MorePosted by Rusty Speidel | Jul 2019
FDA Draft Industry Guidance for Developing Gonadotropin-Releasing Hormone Analogues for Treating...
Read MorePosted by Rusty Speidel | Jun 2019
Risk stratification assessment is feasible and mandatory in UTUC. Identification of tumor grade and stage is essential for optimal treatment selection. Kidney-sparing surgery should be offered in low-risk disease, whereas radical nephroureterectomy and adjuvant chemotherapy should be considered in high-risk disease.
Read MorePosted by Rusty Speidel | Jul 2017
Short Course: Prostate Cancer Prevention, Screening, and Biomarkers About this course: The Prostate Cancer Prevention, Screening, and Biomarkers short course includes sessions from leading urology practitioners and researchers....
Read More